VIVEVE MEDICAL, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0003 USD | 0.00% |
|
+50.00% | +50.00% |
| 2023 | InMode Ltd. acquired Intellectual Property Assets of Viveve Medical Inc. | CI |
| 2023 | Viveve Medical, Inc.(OTCPK:VIVE) dropped from S&P TMI Index | CI |
Presentation Operator MessageOperator (Operator)Good afternoon, and welcome to Viveve's Third ...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Viveve Medical, Inc. designs, develops, manufactures and markets a platform medical technology, Cryogen-cooled Monopolar RadioFrequency (CMRF). The Companyâs CMRF technology is delivered through a radiofrequency generator, handpiece and treatment tip, which collectively, is referred to as the Viveve System. The Viveve System is marketed for the non-invasive treatment of vaginal introital laxity, sexual function, vaginal rejuvenation, and stress urinary incontinence (SUI). In the United States, the Viveve System is indicated for use in general surgical procedures for electrocoagulation and hemostasis. The Viveve System is cleared for marketing in approximately 48 countries throughout the world, including North America, Asia Pacific, Europe, the Middle East and Latin America countries. The Companyâs wholly owned subsidiaries include Viveve, Inc. and Viveve BV.
| 1st Jan change | Capi. | |
|---|---|---|
| +50.00% | 3.22K | |
| +11.73% | 226B | |
| +9.53% | 188B | |
| +14.63% | 137B | |
| +27.47% | 108B | |
| +0.11% | 63.19B | |
| +13.73% | 52.26B | |
| +4.86% | 51B | |
| +7.72% | 43.89B | |
| +7.86% | 38.07B |
- Stock Market
- Equities
- VIVE Stock
- News Viveve Medical, Inc.
- Transcript : Viveve Medical, Inc., Q3 2021 Earnings Call, Nov 11, 2021
